{"url":"https://lda.senate.gov/api/v1/filings/9d169dab-00a4-40cd-a62c-b26a09cb13cf/","filing_uuid":"9d169dab-00a4-40cd-a62c-b26a09cb13cf","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2015,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/9d169dab-00a4-40cd-a62c-b26a09cb13cf/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Will Le","dt_posted":"2016-01-20T15:38:08.297000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1700 K Street NW, Suite 300","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":55291,"url":"https://lda.senate.gov/api/v1/registrants/55291/","house_registrant_id":35132,"name":"BUCHANAN INGERSOLL & ROONEY PC","description":"law firm","address_1":"1700 K Street, NW","address_2":"Suite 300","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"WILL LE","contact_telephone":"+1 202-452-5783","dt_updated":"2026-07-21T10:15:17.911194-04:00"},"client":{"id":159609,"url":"https://lda.senate.gov/api/v1/clients/159609/","client_id":1004595,"name":"CLASADO LIMITED","general_description":"International biotechnology company","client_government_entity":false,"client_self_select":false,"state":null,"state_display":null,"country":"GB","country_display":"United Kingdom","ppb_state":null,"ppb_state_display":null,"ppb_country":"GB","ppb_country_display":"United Kingdom","effective_date":"2015-09-01"},"lobbying_activities":[{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Discussions with DoD regarding field evaluations of certain dietary supplements to address digestive health issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":8641,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"C","last_name":"WILTRAUT","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Discussions with DoD regarding field evaluations of certain dietary supplements to address digestive health issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":8641,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"C","last_name":"WILTRAUT","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}